Tumour Genetic Testing

Solid Tumour Molecular Profiling

GenomixLAB’s Solid Tumour Molecular Profiling is offered using curated biomarker content in across 54 cancer-related genes based on the latest therapy developments, medical guidelines, and clinical trials. The simultaneous analysis of both DNA and RNA facilitates the detection of mutations, Copy Number Variants, and known and novel fusions. Gene fusions are an increasingly important target in precision oncology.

  • 10 unstained Slides
    • Positively charged, unbaked
    • 4-5 micron sections
    • Tissue surface area >5mm x5mm
    • Include 1 H&E slide if available

AND/OR

  • 1 FFPE block (include 1 H&E slide if available)

14 Calendar Days upon receiving the sample.